S
SMAIO SA
PAR:ALSMA
SMAIO SA
PAR:ALSMA
Price:
7.28
EUR
0.55%
Market Closed
Market Cap:
€44.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
SMAIO SA
PAR:ALSMA
|
FR |
|
S
|
Starbucks Corp
SGO:SBUX
|
US |
|
M
|
MDA Ltd
OTC:MDALF
|
CA |
|
Pacific Edge Ltd
NZX:PEB
|
NZ |
|
B
|
Berjaya Philippines Inc
XPHS:BCOR
|
PH |
|
N
|
NanJing GOVA Technology Co Ltd
SSE:688539
|
CN |
|
Staffing 360 Solutions Inc
NASDAQ:STAF
|
US |
|
J
|
Jiangxi Copper Co Ltd
XBER:JIX
|
CN |
|
K
|
Kinhbac City Development Holding Corp
VN:KBC
|
VN |
|
B
|
Bengal & Assam Company Ltd
BSE:533095
|
IN |
|
OPTIMIZERx Corp
NASDAQ:OPRX
|
US |
|
S
|
SVC Industries Ltd
BSE:524488
|
IN |
|
M
|
Mobiltel Iletisim Hizmetleri Sanayi ve Ticaret AS
IST:MOBTL.E
|
TR |
|
Asuransi Harta Aman Pratama Tbk PT
IDX:AHAP
|
ID |
|
Z
|
Zhejiang Yankon Group Co Ltd
SSE:600261
|
CN |
Multiples-Based Value
The Multiples-Based Value of one ALSMA stock under the Base Case scenario is hidden EUR. Compared to the current market price of 7.28 EUR, SMAIO SA is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ALSMA Multiples-Based Value
LOCKED
Multiples Across Competitors
ALSMA Competitors Multiples
SMAIO SA Competitors
SMAIO SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FR |
S
|
SMAIO SA
PAR:ALSMA
|
41.1m EUR | 5 | -22.2 | -35.1 | -17.4 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
174.2B USD | 3.9 | 26.8 | 15.4 | 21.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
160B USD | 16.2 | 57.1 | 43.2 | 53.1 | |
| US |
|
Stryker Corp
NYSE:SYK
|
129.7B USD | 5.3 | 40.9 | 20.8 | 25.2 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
112.9B USD | 3.2 | 24.5 | 13.5 | 19.7 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
91.6B USD | 4.7 | 32.3 | 19.2 | 25.7 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
42.6B EUR | 1.8 | 20.2 | 11.3 | 15.9 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.4B USD | 7.5 | 42.3 | 23.1 | 25.3 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
44.9B USD | 10.6 | 43.2 | 30.6 | 33.9 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.3B USD | 2 | 25.2 | 10 | 16.9 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
33.6B USD | 1.6 | 16.1 | 11.6 | 14 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
